LR Health & Beauty SE Reports Q1 2026 Results

LR Health & Beauty SE has released its preliminary financial figures for the first quarter of 2026, revealing sales of EUR 60.8 million. This represents a 17.8% decline compared to the same period in 2025, where sales reached EUR 74.0 million. The company's normalized EBITDA stood at EUR 5.2 million, down from EUR 8.2 million last year. The decline in EBITDA is attributed to reduced sales and one-off effects from ongoing financial restructuring.

Despite the decreasing sales, LR is advancing its strategic initiatives in 2026 to ensure positive business development. The company has also launched new products during its successful LR Business Days in April, aiming to expand its product portfolio with in-house production of top-selling goods.

LR emphasizes sustainability through its 2025 Sustainability Report, combining economic success with environmental responsibility. The company plans to publish its 2025 Annual Report post-financial restructuring.